- a strong leadership team,
- proven product-market fit, and
- a clear go-to-market strategy.
The stock market turmoil of December 2018 reminds us to never take anything for granted. Still, good investment opportunities exist if you know where to look. My expectation is that 2019 will see significant private equity and venture capital activity thanks to multiple economic factors including a solid M&A appetite.Read More
December 14, 2018
Mission Bio delivers targeted single-cell genomics solutions for high-impact applications with Tapestri, the Precision Genomics Platform. Tapestri is the industry’s first targeted single-cell DNA sequencing platform, enabling precise detection of heterogeneity in disease progression and treatment response. Application areas include blood cancers, solid tumors, and genome editing validation. The platform includes an instrument, consumables, and analysis software, which integrate seamlessly with existing NGS workflows. With Tapestri, researchers have a highly sensitive, targeted, and customizable solution to move precision medicine forward.Read More
In this interview with The Full Ratchet, SC Moatti talks about 13 quick takeaways; including SC’s 3 rules of the most successful products. Explains that “Mobilized” shares examples and case studies implementing those rules.Read More
December 5, 2018
For Skates, 2018 was an especially momentous year. “I turned 30, we raised a Series D and I got engaged this year,” he said. “That’s going to be hard to top.”Read More
November 26, 2018
- Airbnb has hired Amazon VP Dave Stephenson as CFO ahead of its anticipated IPO in 2019.
- Stephenson spent 17 years as Amazon, most recently as VP and CFO of Amazon’s Worldwide Consumer Organization, responsible for all global website sales. He also spent a couple years as President and CFO of Big Fish Games.
- Stephenson is the second Amazon exec to join Airbnb this year, following Greg Greeley, who is president of Homes.
November 19, 2018
Raising a Series A is a huge accomplishment and closing it might feel like you’ve crossed the finish line but the pressure only goes up from here.Read More
Startups working with leading edge technology know that hiring for the most in-demand skills comes with a cost — not just in salary but also in equity grant amounts. The right insight makes reaching your funding goals easier.Read More
When VPs, Directors and Managers sit down to negotiate offer terms, there’s a huge gap between West and East Coast outcomes. In Silicon Valley, candidates command 3-4 times the value in new hire grants compared to those out east. Why the difference, and how should startups position themselves accordingly?Read More
September 25, 2018
Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced a first-of-its-kind study demonstrating its ability to perform single-cell DNA analysis at speed and scale orders of magnitude higher than prior methods. The study, published in Genome Research and co-authored by researchers at Mission Bio and MD Anderson Cancer Center, illustrates its Tapestri platform’s ability to identify the evolution of cellular mutations in Acute Myeloid Leukemia (AML) tumors. This study provides unprecedented insight into the cells that drive complex diseases like cancer and opens the door to the routine sequencing of tumors.Read More